This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Antares Pharma Inc (ATRS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 34.03M 39.07M 52.10M 19.36M
Receivables 3.51M 1.03M 2.23M 2.54M
Inventories 5.86M 6.46M 1.00M 891.76K
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 53.64M 72.66M 77.66M 36.27M
Property, Plant & Equipment, Gross 13.71M 9.31M 5.59M 2.48M
Accumulated Depreciation & Depletion 2.88M 2.36M 2.00M 1.89M
Property, Plant & Equipment, Net 10.83M 6.95M 3.58M 591.67K
Intangibles 2.89M 1.35M 1.12M 952.39K
Other Non-Current Assets 325.96K 6.88M 12.07M 3.06M
Total Non-Current Assets 15.14M 16.27M 17.87M 5.70M
Liabilities & Shareholder Equity
Total Assets 68.77M 88.93M 95.53M 41.96M
Accounts Payable 10.07M 6.38M 2.86M 2.14M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 24.23M 16.36M 7.94M 10.01M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 3.35M 1.86M 1.04M 810.39K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 3.35M 1.86M 1.04M 810.39K
Total Liabilities 27.58M 18.22M 8.98M 10.82M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 41.20M 70.71M 86.55M 31.14M
Common Par 1.32M 1.29M 1.26M 1.04M
Additional Paid In Capital 249.03M 243.38M 238.75M 172.07M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -208.45M -173.30M -152.79M -141.36M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -705.69K -653.20K -665.34K -595.32K
Total Capitalization 41.20M 70.71M 86.55M 31.14M
Total Equity 41.20M 70.71M 86.55M 31.14M
Total Liabilities & Stock Equity 68.77M 88.93M 95.53M 41.96M
Total Common Shares Outstanding 131.74M 128.74M 125.95M 103.55M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 130.55M 126.90M 110.19M 96.99M
Diluted Weighted Shares Outstanding 130.55M 126.90M 110.19M 96.99M
Number of Employees 93 60 42 29
Number of Part-Time Employees 0 0 0 0
ATRS News

ATRS Antares Pharma Inc

Analysts Ratings for ATRS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ATRS ANALYST REPORT

Brokerage Partners

ATRS Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs